Board Meeting11 Aug 2026, 06:10 pm
Biofil Chemicals Board Approves Q1 FY27 Un-Audited Results
AI Summary
Biofil Chemicals & Pharmaceuticals Ltd announced that its Board of Directors, in a meeting held on August 11, 2026, approved the un-audited financial results for the quarter ended June 30, 2026. The board also approved the Board's Report, Corporate Governance Report, and Management Discussion and Analysis Report for the year ended March 31, 2026. Additionally, the company will convene its 41st Annual General Meeting on September 23, 2026, via Video Conferencing. The continuation of Mr. Ashok Kumar Ramawat's directorship was also approved.
Key Highlights
- Board approved un-audited financial results for Q1 FY27.
- Board's Report, Corporate Governance, and MD&A for FY26 approved.
- 41st AGM scheduled for September 23, 2026, via VC/OAVM.
- Continuation of Non-Executive Independent Director approved.
- Financial results to be published on company and exchange websites.
Price Impact
More from BIOFILCHEM